Group A and Group C Meningococcal Polysaccharide Vaccine - Global and China Top Players Market Share and Ranking 2023
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the research report, the global market for Group A and Group C Meningococcal Polysaccharide Vaccine should grow from US$ 285 million in 2022 to US$ 425.5 million by 2029, with a CAGR of 5.9% for the period of 2023-2029.
Meningococcal disease, caused by Neisseria meningitidis, can cause serious illness and even death. The global burden of meningococcal disease, especially serogroups A and C, drives the need for effective vaccines to prevent these infections.
After vaccination, the body can produce a humoral immune response. It is used to prevent infectious diseases caused by group A and group C meningococci, such as cerebrospinal meningitis and pneumonia.
This report studies and analyses global Group A and Group C Meningococcal Polysaccharide Vaccine status and future trends, helps the client to determine the Group A and Group C Meningococcal Polysaccharide Vaccine market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Group A and Group C Meningococcal Polysaccharide Vaccine, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Group A and Group C Meningococcal Polysaccharide Vaccine market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Group A and Group C Meningococcal Polysaccharide Vaccine sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Group A and Group C Meningococcal Polysaccharide Vaccine sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Group A and Group C Meningococcal Polysaccharide Vaccine key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Group A and Group C Meningococcal Polysaccharide Vaccine key producing regions, capacity, production, and year over year growth
(6) Group A and Group C Meningococcal Polysaccharide Vaccine industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Walvax
Lanzhou Institute of Biological Products
AIM Bio
Sanofi Pasteur
GSK
Hualan Bio
ZFSW
Changsheng
Kanghua Bio
Market segment by Type, covers
Class 1 Vaccine
Class II Vaccine
Market segment by Application, can be divided into
Hospital
Clinic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Group A and Group C Meningococcal Polysaccharide Vaccine product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Group A and Group C Meningococcal Polysaccharide Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Group A and Group C Meningococcal Polysaccharide Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Group A and Group C Meningococcal Polysaccharide Vaccine, percent & CAGR, 2018-2029
Chapter 5: Group A and Group C Meningococcal Polysaccharide Vaccine industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Group A and Group C Meningococcal Polysaccharide Vaccine Definition
1.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast
1.2.1 By Consumption Value, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size，2018-2029
1.2.2 By Sales Quantity, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size，2018-2029
1.2.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP)，2018-2029
1.3 China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size and Forecast
1.3.1 By Consumption Value, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size，2018-2029
1.3.2 By Sales Quantity, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size，2018-2029
1.3.3 China Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP)， 2018-2029
1.4 Share of China Group A and Group C Meningococcal Polysaccharide Vaccine Market with Respect to the Global Market
1.4.1 By Consumption Value, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Share in Global, 2018-2029
1.4.3 Group A and Group C Meningococcal Polysaccharide Vaccine Market Size: China VS Global, 2018-2029
1.5 Group A and Group C Meningococcal Polysaccharide Vaccine Market Dynamics
1.5.1 Group A and Group C Meningococcal Polysaccharide Vaccine Market Drivers
1.5.2 Group A and Group C Meningococcal Polysaccharide Vaccine Market Restraints
1.5.3 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Trends
1.5.4 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Group A and Group C Meningococcal Polysaccharide Vaccine, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Group A and Group C Meningococcal Polysaccharide Vaccine, Global Market Share by Company, 2018-2023
2.3 Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Group A and Group C Meningococcal Polysaccharide Vaccine Concentration Ratio
2.6 Global Group A and Group C Meningococcal Polysaccharide Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Product Type
2.8 Head Office and Group A and Group C Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
2.9 Group A and Group C Meningococcal Polysaccharide Vaccine Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Group A and Group C Meningococcal Polysaccharide Vaccine, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Group A and Group C Meningococcal Polysaccharide Vaccine, China Market Share by Company, 2018-2023
3.3 China Group A and Group C Meningococcal Polysaccharide Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity by Region
4.3 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region, 2018-2029
4.5 Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain
5.2 Group A and Group C Meningococcal Polysaccharide Vaccine Upstream Analysis
5.2.1 Group A and Group C Meningococcal Polysaccharide Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Group A and Group C Meningococcal Polysaccharide Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Group A and Group C Meningococcal Polysaccharide Vaccine Production Mode
5.6 Group A and Group C Meningococcal Polysaccharide Vaccine Procurement Model
5.7 Group A and Group C Meningococcal Polysaccharide Vaccine Industry Sales Model and Sales Channels
5.7.1 Group A and Group C Meningococcal Polysaccharide Vaccine Sales Model
5.7.2 Group A and Group C Meningococcal Polysaccharide Vaccine Typical Distributors
6 Sights by Type
6.1 Group A and Group C Meningococcal Polysaccharide Vaccine Classification
6.1.1 Class 1 Vaccine
6.1.2 Class II Vaccine
6.2 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029
6.4 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029
6.5 By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Group A and Group C Meningococcal Polysaccharide Vaccine Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029
7.4 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029
7.5 By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029
8.3 By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Group A and Group C Meningococcal Polysaccharide Vaccine & Forecasts, 2018-2029
8.4.2 By Country, North America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Group A and Group C Meningococcal Polysaccharide Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029
9.3 By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.4.2 By Type, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.5.2 By Type, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.6.2 By Type, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.7.2 By Type, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.8.2 By Type, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.10.2 By Type, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Walvax
10.1.1 Walvax Company Information, Head Office, Market Area, and Industry Position
10.1.2 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
10.1.3 Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Walvax Company Profile and Main Business
10.1.5 Walvax Recent Developments
10.2 Lanzhou Institute of Biological Products
10.2.1 Lanzhou Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position
10.2.2 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
10.2.3 Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Lanzhou Institute of Biological Products Company Profile and Main Business
10.2.5 Lanzhou Institute of Biological Products Recent Developments
10.3 AIM Bio
10.3.1 AIM Bio Company Information, Head Office, Market Area, and Industry Position
10.3.2 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
10.3.3 AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 AIM Bio Company Profile and Main Business
10.3.5 AIM Bio Recent Developments
10.4 Sanofi Pasteur
10.4.1 Sanofi Pasteur Company Information, Head Office, Market Area, and Industry Position
10.4.2 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
10.4.3 Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Sanofi Pasteur Company Profile and Main Business
10.4.5 Sanofi Pasteur Recent Developments
10.5 GSK
10.5.1 GSK Company Information, Head Office, Market Area, and Industry Position
10.5.2 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
10.5.3 GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 GSK Company Profile and Main Business
10.5.5 GSK Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Company Information, Head Office, Market Area, and Industry Position
10.6.2 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
10.6.3 Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Hualan Bio Company Profile and Main Business
10.6.5 Hualan Bio Recent Developments
10.7 ZFSW
10.7.1 ZFSW Company Information, Head Office, Market Area, and Industry Position
10.7.2 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
10.7.3 ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 ZFSW Company Profile and Main Business
10.7.5 ZFSW Recent Developments
10.8 Changsheng
10.8.1 Changsheng Company Information, Head Office, Market Area, and Industry Position
10.8.2 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
10.8.3 Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Changsheng Company Profile and Main Business
10.8.5 Changsheng Recent Developments
10.9 Kanghua Bio
10.9.1 Kanghua Bio Company Information, Head Office, Market Area, and Industry Position
10.9.2 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
10.9.3 Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Kanghua Bio Company Profile and Main Business
10.9.5 Kanghua Bio Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Group A and Group C Meningococcal Polysaccharide Vaccine Market Restraints
Table 3. Group A and Group C Meningococcal Polysaccharide Vaccine Market Trends
Table 4. Group A and Group C Meningococcal Polysaccharide Vaccine Industry Policy
Table 5. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Group A and Group C Meningococcal Polysaccharide Vaccine Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Group A and Group C Meningococcal Polysaccharide Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Group A and Group C Meningococcal Polysaccharide Vaccine Manufacturers Product Type
Table 13. Head Office and Group A and Group C Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
Table 14. Group A and Group C Meningococcal Polysaccharide Vaccine Capacity of Major Manufacturers and Future Plan
Table 15. China Group A and Group C Meningococcal Polysaccharide Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production by Region, 2018-2023, (K Units)
Table 20. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Group A and Group C Meningococcal Polysaccharide Vaccine Upstream (Raw Materials)
Table 22. Global Group A and Group C Meningococcal Polysaccharide Vaccine Typical Customers
Table 23. Group A and Group C Meningococcal Polysaccharide Vaccine Typical Distributors
Table 24. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2018-2029
Table 34. Walvax Company Information, Head Office, Market Area, and Industry Position
Table 35. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
Table 36. Walvax Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Walvax Company Profile and Main Business
Table 38. Walvax Recent Developments
Table 39. Lanzhou Institute of Biological Products Company Information, Head Office, Market Area, and Industry Position
Table 40. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
Table 41. Lanzhou Institute of Biological Products Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Lanzhou Institute of Biological Products Company Profile and Main Business
Table 43. Lanzhou Institute of Biological Products Recent Developments
Table 44. AIM Bio Company Information, Head Office, Market Area, and Industry Position
Table 45. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
Table 46. AIM Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. AIM Bio Company Profile and Main Business
Table 48. AIM Bio Recent Developments
Table 49. Sanofi Pasteur Company Information, Head Office, Market Area, and Industry Position
Table 50. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
Table 51. Sanofi Pasteur Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Sanofi Pasteur Company Profile and Main Business
Table 53. Sanofi Pasteur Recent Developments
Table 54. GSK Company Information, Head Office, Market Area, and Industry Position
Table 55. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
Table 56. GSK Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. GSK Company Profile and Main Business
Table 58. GSK Recent Developments
Table 59. Hualan Bio Company Information, Head Office, Market Area, and Industry Position
Table 60. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
Table 61. Hualan Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Hualan Bio Company Profile and Main Business
Table 63. Hualan Bio Recent Developments
Table 64. ZFSW Company Information, Head Office, Market Area, and Industry Position
Table 65. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
Table 66. ZFSW Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. ZFSW Company Profile and Main Business
Table 68. ZFSW Recent Developments
Table 69. Changsheng Company Information, Head Office, Market Area, and Industry Position
Table 70. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
Table 71. Changsheng Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Changsheng Company Profile and Main Business
Table 73. Changsheng Recent Developments
Table 74. Kanghua Bio Company Information, Head Office, Market Area, and Industry Position
Table 75. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Models, Specifications, and Application
Table 76. Kanghua Bio Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Kanghua Bio Company Profile and Main Business
Table 78. Kanghua Bio Recent Developments
List of Figures
Figure 1. Group A and Group C Meningococcal Polysaccharide Vaccine Picture
Figure 2. Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity (K Units) & (2018-2029)
Figure 7. China Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Group A and Group C Meningococcal Polysaccharide Vaccine Market Share of Global, 2018-2029
Figure 10. Global Group A and Group C Meningococcal Polysaccharide Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Group A and Group C Meningococcal Polysaccharide Vaccine Key Participants, Market Share, 2022
Figure 12. Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Group A and Group C Meningococcal Polysaccharide Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Group A and Group C Meningococcal Polysaccharide Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 15. Group A and Group C Meningococcal Polysaccharide Vaccine Industry Chain
Figure 16. Group A and Group C Meningococcal Polysaccharide Vaccine Procurement Model
Figure 17. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Model
Figure 18. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Channels, Direct Sales, and Distribution
Figure 19. Class 1 Vaccine
Figure 20. Class II Vaccine
Figure 21. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Hospital
Figure 27. Clinic
Figure 28. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value, 2018-2029, US$ Million
Figure 29. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2018-2029
Figure 30. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 31. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2018-2029
Figure 32. By Application, Global Group A and Group C Meningococcal Polysaccharide Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 33. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2018-2029
Figure 34. By Region, Global Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2018-2029
Figure 35. North America Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 36. By Country, North America Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2022
Figure 37. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2022
Figure 39. Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country/Region, Asia Pacific Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2022
Figure 41. South America Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, South America Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value Market Share, 2022
Figure 43. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 45. By Type, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 46. By Application, U.S. Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 47. Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, Europe Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 50. China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, China Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 53. Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, Japan Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 56. South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, South Korea Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 59. Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, Southeast Asia Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 62. India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, India Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 65. Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, Middle East & Africa Group A and Group C Meningococcal Polysaccharide Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 68. Research Methodology
Figure 69. Breakdown of Primary Interviews
Figure 70. Bottom-up and Top-down Approaches
Figure 71. Top-down Approaches
Research Methodology:
Group A and Group C Meningococcal Polysaccharide Vaccine Global and China Top Players Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|